泰林生物：股东高得投资拟减持不超过1.5%公司股份

Core Viewpoint - Gao De Investment, a major shareholder and controlling entity of Tailin Bio (300813.SZ), plans to reduce its stake by up to 1.5% of the company's total shares within three months following the announcement of the reduction plan [1] Group 1 - Gao De Investment holds over 5% of Tailin Bio's shares and intends to sell a maximum of 1,819,517 shares [1] - The planned reduction will be executed through centralized bidding, block trading, or a combination of both methods [1] - The selling price will be determined based on the market price of the shares at the time of the reduction [1]